Researchers at Uppsala University and KTH Royal Institute of Technology have developed a new form of precision medicine, an antibody, with the potential to treat several types of cancer. Researchers have managed to combine three different functions in the antibody, which together strongly amplify the effect of T cells on the cancer tumour. The study has been published in Nature Communications.
Researchers have discovered that bank voles in Skåne, southern Sweden, carry a virus that can cause hemorrhagic fever in humans. This finding was made more than 500 km south of the previously known range. This is revealed in a new study from Uppsala University. The researchers were surprised that such a high proportion of the relatively few voles they caught were actually carrying a hantavirus.
Women with a type of ovarian cancer known as germ cell tumours have a worse prognosis than men with similar tumours, i.e. testicular cancer. After five years with the disease, 98 percent of men were alive while the survival rate for women was only 85 percent. This has been revealed by a new study from Uppsala University and Uppsala University Hospital published in the Journal of Internal Medicine.
Upper secondary school students were less likely to seek help for mental ill health when they were forced to study at home during the pandemic. A similar decrease was not seen for secondary school students aged 14–16 who remained in school. This has been shown in a new study at Uppsala University, based on data covering all of Sweden's upper secondary school students between 2015–2021.
The frequency of mast cell progenitors in the blood circulation is higher in asthma patients during the birch pollen season than outside of it. This has been demonstrated in a new study by Uppsala University, published in the scholarly journal Allergy.
There was a significant difference in the speed with which different groups were vaccinated against COVID-19. One explanation could be that people absorb information and make decisions in different ways. A new study shows that among people with the highest cognitive ability, 80% had been vaccinated within 50 days. Among those with the lowest cognitive ability, it took 180 days to achieve the same
Researchers from the Zoonosis Science Center at Uppsala University have identified a new coronavirus. Their study of approximately 260 bank voles caught around Grimsö, Örebro County, shows that the virus is well established in Sweden’s red-backed voles. The finding has been published in the journal Viruses.
In COVID Symptom Study Sweden more than 10 million daily reports from participants in COVID Symptom Study Sweden from April 2020 to February 2021. The scope of the study was to develop and evaluate a framework to estimate the regional prevalence of COVID-19 using symptom-based surveillance, and to test if these prevalence estimates could be used to predict subsequent trends in COVID-19 admissions.
Researchers have developed and used a new method to map interactions on a large scale between human proteins and coronavirus proteins, which has provided valuable new information. In collaborations with others, they show that blocking one of these interactions inhibited infection of human cells by SARS-CoV-2. They also confirmed the interaction between the viral protein and the human protein.
The current COVID-19 pandemic has highlighted the need for methods to identify new or repurposed drugs as antivirals. Researchers at Uppsala University and Karolinska Institutet are now presenting a new screening approach that focuses on the identification of virus-specific morphological changes in virus-infected cells.
Uppsala University has joined the Leap Health Breakthrough Network, a global group of 21 leading academic and research institutions committed to solving the world’s most serious health challenges — such as cancer and infectious diseases — at record speed. Wellcome Leap is a US-based non-profit organisation founded by the Wellcome Trust to accelerate innovations that benefit global health.
Researchers at Uppsala University have found that an effective way of treating the coronavirus behind the 2003 SARS epidemic also works on the closely related SARS-CoV-2 virus, the culprit in the ongoing COVID-19 pandemic. The substance concerned is nitric oxide (NO), a compound with antiviral properties that is produced by the body itself. The study is published in the journal Redox Biology.
Why so many COVID-19 patients get blood clots (thrombosis) remains uncertain. But scientists at Uppsala University and the University Hospital have now identified a mechanism they believe to be implicated. A particular protein triggers a part of our immune system that can boost the blood’s tendency to coagulate and form clots. The study is now published in Thrombosis and Haemostasis.
Viruses have a very limited set of genes and therefore must use the cellular machineries of their hosts for most parts of their growth. A new study, led by scientists at Uppsala University, has discovered a specific host protein that many viruses use for their transport within the cell. The discovery opens up new possibilities to develop a broad spectrum anti-viral therapy.
Warding off the threats of future epidemics will be difficult without better cooperation and contingency plans that allow us to act before a crisis hits. This is one message in a new report summarising the discussions of the Uppsala Health Summit on the theme of Tackling Infectious Disease Threats: Prevent, Detect and Respond with a One Health Approach, which took place in October last year.
At the Uppsala Health Summit Tackling Infectious Disease Threats, due to start next week, experts and decision makers from ministries, academia, companies and voluntary organisations are meeting to discuss how jointly to reduce the risk of severe outbreaks.
Infectious diseases are among the biggest threats to health in the world. Recurrent alarms about the risk of disease spread, epidemics and pandemics make the subject highly topical and evoke anxiety in many of us. In a report published today, Uppsala Health Summit lays the basis for discussion at the summit on 10–11 October on how to manage the threats.
Despite remarkable gains in health over the last century, infectious diseases remain a major threat. Alarming reports on outbreaks of Zika, Ebola or avian flu serve as reminders of the gravity of the situation. At the high-level meeting Uppsala Health Summit, international experts will gather from different sectors to discuss how to reduce the threats.
In just a few decades, the number of overweight and obese adults and children in the world has reached alarming levels, not least in low-income countries. This year, Uppsala Health Summit is taking place in conjunction with World Obesity Day: 11-12 October 2016. International experts on child obesity will gather to discuss countermeasures with industry, policy makers and society.
In a study published this month in Malaria Journal, researchers from Uppsala University and other institutions present a new model for systematically evaluating new malaria treatment programs in routine conditions across multiple countries.
Founded in 1477, Uppsala University is the oldest university in Sweden. With more than 50,000 students and 7,500 employees in Uppsala and Visby, we are a broad university with research in social sciences, humanities, technology, natural sciences, medicine and pharmacology. Our mission is to conduct education and research of the highest quality and relevance to society on a long-term basis. Uppsala University is regularly ranked among the world’s top universities.
Dag Hammarskjölds väg 7
BOX 256, 751 05 Uppsala
Sweden